Ziprasidone and the pharmacokinetics of a combined oral contraceptive (Q36055480)

11 August 2017

Ziprasidone and the pharmacokinetics of a combined oral contraceptive (English)

1 reference

11 August 2017

1 reference

G J Muirhead

1

1 reference

11 August 2017

J Harness

2

1 reference

11 August 2017

P R Holt

3

1 reference

11 August 2017

S Oliver

4

1 reference

11 August 2017

R J Anziano

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

49 Suppl 1

1 reference

11 August 2017

49S-56S

1 reference

Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Women and schizophrenia: a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Estrogen control of central neurotransmission: effect on mood, mental state, and memory.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

The role of estrogens in schizophrenia gender differences

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Species differences in metabolism and pharmacokinetics: are we close to an understanding?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Gender and Schizophrenia Results of an Epidemiologically-based Family Study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Pharmacokinetic Drug Interactions with Oral Contraceptives

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

A study of serum prolactin levels in schizophrenia: comparison of males and females

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Risperidone-induced prolactin elevations in premenopausal women with schizophrenia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015051

Epidemiology of Schizophrenia

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00153.X

1983 metropolitan height and weight tables

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10771454

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetics and antipsychotic effect of remoxipride in chronic schizophrenic patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10771454

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10771454

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.1365-2125.2000.00153.X

1 reference

11 August 2017

1 reference

11 August 2017

1 reference